Chronic cerebrospinal venous insufficiency and multiple sclerosisOmar Khan, Robert P. Lisak, Massimo Filippi et al.|Annals of Neurology|2010Cited by 140
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trialBruce Cree, Piotr Sokolowski, Gıancarlo Comı et al.|The Lancet Neurology|2020Cited by 104